Future of Insulin Delivery Devices Market with CAGR Analysis 2018-2023 and Major Key Players: Animas, Becton, Dickinson, Biocon, ELI Lilly, Insulet, Medtronic PLC, Novo Nordisk A/S

Marketprognosis.com Publish a New Market Research Report On “Insulin Delivery Devices Market - Segmented by Type, End User and Geography - Growth, Trends, and Forecast (2018 - 2023)” which contains global key player’s survey information and forecast to 2023.

Overview of the Global Insulin Delivery Devices Market:

The Global Insulin Delivery Devices Market is projected to register a CAGR of 5.7% during the forecast period. The major drivers in the market include favorable reimbursement scenario and government support in selected countries, technological advancements in insulin delivery devices, and growing diabetic population.

The rapidly spreading epidemic of diabetes across the world has kept the interest level in diabetes-related R&D immensely high in the recent years. Despite the condition affecting millions of people worldwide, scientists, and researchers have not been able to find a cure for the disease and controlling it by the effective and timely administration of insulin remains an indispensable measure for patients with type-1 diabetes to lead a normal life. Thus, in the absence of a complete and effective cure for diabetes, the emphasis largely lies on making insulin therapy better and more successful. As a result, the continuous quest for new and pioneering therapies and insulin delivery measures continues and is reflecting positively on the overall global market for insulin delivery devices.

Get a Sample Copy of this Report @ https://www.marketprognosis.com/sample-request/15773 .

According to a study published in the NCBI adherence to insulin therapy was noted in 77% of the Study subjects and this was similar between people with type 1 diabetes and those with type 2 diabetes. The average glucose levels were significantly higher in those who admitted to non-insulin adherence compared to those who adhered to their insulin regimen. Reasons proffered by respondents for non-insulin adherence included 41% due to high costs, 41% due to inconvenience, and 18% due to needle pain. This study clearly indicates that high costs of insulin are a major deterrent for people when it comes to insulin adherence as most of the population in the developing nations is not insured and the government policies for reimbursement does not support the patients to be able to afford the services. This would ultimately lead to the slowdown of the growth of the market.

Geographically, North America is estimated to reign the insulin delivery devices industry in the year 2015. The rising diabetic population and the accessibility of technologically advanced devices are the factors contributing to the high market growth in North America. According to statistics by CDC in 2016, around 29 million people in the U.S. are still suffering from diabetes, among them 21.0 million patients were diagnosed, whereas 8.1 million patients remained undiagnosed.

Purchase this report online with Top Key Players Analysis and List of Tables & Figure @ https://www.marketprognosis.com/buyReport/15773 .

Major Key Players:

1 Animas Corporation (Johnson and Johnson)

2 Becton

3 Dickinson and Company

4 Biocon Limited

5 ELI Lilly and Company

6 Insulet Corporation

7 Medtronic PLC

8 Novo Nordisk A/S and More…………….

What Information does this report contain?

1 A detailed analysis of regulatory trends, drivers, industry pitfalls, challenges and growth opportunities for participants

2 Which are the leading market products, applications & regions and how will they perform by 2023?

3 What are the technologies & innovation trends, how will they evolve by 2023?

4 Which companies lead the industry, how are they positioned in the market in terms of sustainability, competency, production capacity and strategic outlook?

Any Query? Ask to our Expert @ https://www.marketprognosis.com/enquiry/15773 .

In the end, this report covers data and information on capacity and production overview, production, market share analysis, sales overview, supply, sales, and shortage, import, export and consumption as well as cost, price, revenue and gross margin of Insulin Delivery Devices Market.

Table of Contents:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Key Inferences

5 Market Overview

6 Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

7 Market Segmentation

8 Competitive Landscape

9 Key Players

About us:

We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today’s complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

Contact us:

ProgMark Pvt. Ltd.
Thane – 421501
India.

sales@marketprognosis.com
+1 973 241 5193
https://www.marketprognosis.com

This release was published on openPR.